Advertisement

Index by author

May 01, 2013; Volume 345,Issue 2

A

  1. Abais, Justine M.

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  2. Abood, Mary E.

    1. Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
      Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

  3. Agarwal, Chapla

    1. Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
      Samiha Mateen, Komal Raina, Chapla Agarwal, Daniel Chan and Rajesh Agarwal
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 206-214; DOI: https://doi.org/10.1124/jpet.113.203471

  4. Agarwal, Rajesh

    1. Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
      Samiha Mateen, Komal Raina, Chapla Agarwal, Daniel Chan and Rajesh Agarwal
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 206-214; DOI: https://doi.org/10.1124/jpet.113.203471

  5. Ancona, Silvia

    1. Chromatin Remodeling by Rosuvastatin Normalizes TSC2-/meth Cell Phenotype through the Expression of Tuberin
      Elena Lesma, Silvia Ancona, Emanuela Orpianesi, Vera Grande, Anna Maria Di Giulio and Alfredo Gorio
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 180-188; DOI: https://doi.org/10.1124/jpet.113.203141

B

  1. Barrett, Victoria J.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  2. Blair, Ian A.

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  3. Boini, Krishna M.

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  4. Bouchara, Jean-Philippe

    1. Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
      Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

  5. Buckley, Peter T.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  6. Burman, Miriam

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  7. Bykova, Ekaterina

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

C

  1. Carlson, Stephen L.

    1. Ethanol Activation of Protein Kinase A Regulates GABAA α1 Receptor Function and Trafficking in Cultured Cerebral Cortical Neurons
      Stephen L. Carlson, Sandeep Kumar, David F. Werner, Christopher E. Comerford and A. Leslie Morrow
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 317-325; DOI: https://doi.org/10.1124/jpet.112.201954

  2. Catterall, William A.

    1. Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
      John C. Oakley, Alvin R. Cho, Christine S. Cheah, Todd Scheuer and William A. Catterall
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 215-224; DOI: https://doi.org/10.1124/jpet.113.203331

  3. Chan, Daniel

    1. Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
      Samiha Mateen, Komal Raina, Chapla Agarwal, Daniel Chan and Rajesh Agarwal
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 206-214; DOI: https://doi.org/10.1124/jpet.113.203471

  4. Chatterjee, Shampa

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  5. Cheah, Christine S.

    1. Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
      John C. Oakley, Alvin R. Cho, Christine S. Cheah, Todd Scheuer and William A. Catterall
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 215-224; DOI: https://doi.org/10.1124/jpet.113.203331

  6. Cho, Alvin R.

    1. Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
      John C. Oakley, Alvin R. Cho, Christine S. Cheah, Todd Scheuer and William A. Catterall
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 215-224; DOI: https://doi.org/10.1124/jpet.113.203331

  7. Chuang, Victor Tuan Giam

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

  8. Colombero, Anne

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

  9. Comerford, Christopher E.

    1. Ethanol Activation of Protein Kinase A Regulates GABAA α1 Receptor Function and Trafficking in Cultured Cerebral Cortical Neurons
      Stephen L. Carlson, Sandeep Kumar, David F. Werner, Christopher E. Comerford and A. Leslie Morrow
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 317-325; DOI: https://doi.org/10.1124/jpet.112.201954

  10. Court, Michael H.

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

D

  1. DaCosta, Christopher

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

  2. DeHaas, Christopher J.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  3. Di Giulio, Anna Maria

    1. Chromatin Remodeling by Rosuvastatin Normalizes TSC2-/meth Cell Phenotype through the Expression of Tuberin
      Elena Lesma, Silvia Ancona, Emanuela Orpianesi, Vera Grande, Anna Maria Di Giulio and Alfredo Gorio
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 180-188; DOI: https://doi.org/10.1124/jpet.113.203141

  4. Ding, Zhi-Ming

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

  5. Diquet, Bertrand

    1. Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
      Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

  6. Dodia, Chandra

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  7. Duan, Su X.

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

E

  1. Elliott, Robin

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

F

  1. Feinstein, Sheldon I.

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  2. Fisher, Aron B.

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  3. Foley, James J.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  4. Franconi, Florence

    1. Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
      Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

  5. Freytsis, Marina

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

G

  1. Gaida, Kevin

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

  2. Godon, Charlotte

    1. Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
      Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

  3. Gorio, Alfredo

    1. Chromatin Remodeling by Rosuvastatin Normalizes TSC2-/meth Cell Phenotype through the Expression of Tuberin
      Elena Lesma, Silvia Ancona, Emanuela Orpianesi, Vera Grande, Anna Maria Di Giulio and Alfredo Gorio
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 180-188; DOI: https://doi.org/10.1124/jpet.113.203141

  4. Grande, Vera

    1. Chromatin Remodeling by Rosuvastatin Normalizes TSC2-/meth Cell Phenotype through the Expression of Tuberin
      Elena Lesma, Silvia Ancona, Emanuela Orpianesi, Vera Grande, Anna Maria Di Giulio and Alfredo Gorio
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 180-188; DOI: https://doi.org/10.1124/jpet.113.203141

  5. Greenblatt, David J.

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

  6. Greer, Jennifer

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

  7. Guillemette, Chantal

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

H

  1. Hamasaki, Keisuke

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

  2. Harris, Angela

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

  3. Hay, Douglas W. P.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  4. Hazarika, Suwagmani

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

  5. Ho, Shu-Yin

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

  6. Hu, Sylvia

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

I

  1. Ishima, Yu

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

J

  1. Jadhav, Ashok

    1. The Heme Oxygenase System Selectively Enhances the Anti-Inflammatory Macrophage-M2 Phenotype, Reduces Pericardial Adiposity, and Ameliorated Cardiac Injury in Diabetic Cardiomyopathy in Zucker Diabetic Fatty Rats
      Ashok Jadhav, Shuchita Tiwari, Paul Lee and Joseph Fomusi Ndisang
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 239-249; DOI: https://doi.org/10.1124/jpet.112.200808

  2. Jain, Mahendra

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

K

  1. Kapur, Ankur

    1. Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
      Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

  2. Kelley, Laura

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

  3. Kodama, Azusa

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

  4. Kotzer, Charles J.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  5. Kumar, Sandeep

    1. Ethanol Activation of Protein Kinase A Regulates GABAA α1 Receptor Function and Trafficking in Cultured Cerebral Cortical Neurons
      Stephen L. Carlson, Sandeep Kumar, David F. Werner, Christopher E. Comerford and A. Leslie Morrow
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 317-325; DOI: https://doi.org/10.1124/jpet.112.201954

L

  1. Lainé, Dramane I.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  2. Lee, Intae

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  3. Lee, Paul

    1. The Heme Oxygenase System Selectively Enhances the Anti-Inflammatory Macrophage-M2 Phenotype, Reduces Pericardial Adiposity, and Ameliorated Cardiac Injury in Diabetic Cardiomyopathy in Zucker Diabetic Fatty Rats
      Ashok Jadhav, Shuchita Tiwari, Paul Lee and Joseph Fomusi Ndisang
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 239-249; DOI: https://doi.org/10.1124/jpet.112.200808

  4. Lee, William M.

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

  5. Legras, Pierre

    1. Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
      Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

  6. Lelièvre, Bénédicte

    1. Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
      Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

  7. Lesma, Elena

    1. Chromatin Remodeling by Rosuvastatin Normalizes TSC2-/meth Cell Phenotype through the Expression of Tuberin
      Elena Lesma, Silvia Ancona, Emanuela Orpianesi, Vera Grande, Anna Maria Di Giulio and Alfredo Gorio
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 180-188; DOI: https://doi.org/10.1124/jpet.113.203141

  8. Li, Pin-Lan

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  9. Li, Xiang

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  10. Lin, Fen-Fen

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

  11. Luttmann, Mark A.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

M

  1. Makriyannis, Alexandros

    1. Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
      Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

  2. Marcu, Jahan

    1. Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
      Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

  3. Maruyama, Toru

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

  4. Mateen, Samiha

    1. Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
      Samiha Mateen, Komal Raina, Chapla Agarwal, Daniel Chan and Rajesh Agarwal
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 206-214; DOI: https://doi.org/10.1124/jpet.113.203471

  5. McBride, Helen J.

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

  6. Mesaros, Clementina

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  7. Mizushima, Tohru

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

  8. Moksa, Angelica

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

  9. Moore, Chad D.

    1. Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
      Jessica K. Roberts, Chad D. Moore, Robert M. Ward, Garold S. Yost and Christopher A. Reilly
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 308-316; DOI: https://doi.org/10.1124/jpet.112.202556

  10. Morrow, A. Leslie

    1. Ethanol Activation of Protein Kinase A Regulates GABAA α1 Receptor Function and Trafficking in Cultured Cerebral Cortical Neurons
      Stephen L. Carlson, Sandeep Kumar, David F. Werner, Christopher E. Comerford and A. Leslie Morrow
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 317-325; DOI: https://doi.org/10.1124/jpet.112.201954

  11. Mseeh, Faika

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

N

  1. Ndisang, Joseph Fomusi

    1. The Heme Oxygenase System Selectively Enhances the Anti-Inflammatory Macrophage-M2 Phenotype, Reduces Pericardial Adiposity, and Ameliorated Cardiac Injury in Diabetic Cardiomyopathy in Zucker Diabetic Fatty Rats
      Ashok Jadhav, Shuchita Tiwari, Paul Lee and Joseph Fomusi Ndisang
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 239-249; DOI: https://doi.org/10.1124/jpet.112.200808

  2. Nguyen, Hung Q.

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

O

  1. Oakley, John C.

    1. Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
      John C. Oakley, Alvin R. Cho, Christine S. Cheah, Todd Scheuer and William A. Catterall
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 215-224; DOI: https://doi.org/10.1124/jpet.113.203331

  2. Orpianesi, Emanuela

    1. Chromatin Remodeling by Rosuvastatin Normalizes TSC2-/meth Cell Phenotype through the Expression of Tuberin
      Elena Lesma, Silvia Ancona, Emanuela Orpianesi, Vera Grande, Anna Maria Di Giulio and Alfredo Gorio
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 180-188; DOI: https://doi.org/10.1124/jpet.113.203141

  3. Otagiri, Masaki

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

P

  1. Palovich, Michael R.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  2. Peter, Inga

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

  3. Powell, David R.

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

R

  1. Raina, Komal

    1. Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
      Samiha Mateen, Komal Raina, Chapla Agarwal, Daniel Chan and Rajesh Agarwal
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 206-214; DOI: https://doi.org/10.1124/jpet.113.203471

  2. Rathanaswami, Palaniswami

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

  3. Reggio, Patricia H.

    1. Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
      Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

  4. Reilly, Christopher A.

    1. Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
      Jessica K. Roberts, Chad D. Moore, Robert M. Ward, Garold S. Yost and Christopher A. Reilly
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 308-316; DOI: https://doi.org/10.1124/jpet.112.202556

  5. Roberts, Jessica K.

    1. Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
      Jessica K. Roberts, Chad D. Moore, Robert M. Ward, Garold S. Yost and Christopher A. Reilly
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 308-316; DOI: https://doi.org/10.1124/jpet.112.202556

  6. Rumsey, William L.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

S

  1. Saint-André, Jean-Paul

    1. Experimental Models of Disseminated Scedosporiosis with Cerebral Involvement
      Bénédicte Lelièvre, Pierre Legras, Charlotte Godon, Florence Franconi, Jean-Paul Saint-André, Jean-Philippe Bouchara and Bertrand Diquet
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 198-205; DOI: https://doi.org/10.1124/jpet.112.201541

  2. Salmon, Michael

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  3. Sands, Arthur

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

  4. Sarau, Henry M.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  5. Scheuer, Todd

    1. Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
      John C. Oakley, Alvin R. Cho, Christine S. Cheah, Todd Scheuer and William A. Catterall
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 215-224; DOI: https://doi.org/10.1124/jpet.113.203331

  6. Schmidt, Dulcie B.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  7. Shadoan, Melanie K.

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

  8. Shore, Derek M.

    1. Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
      Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

  9. Slack, Robert J.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  10. Smith, Melinda

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

  11. Sullivan, John K.

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

T

  1. Tanaka, Ken-ichiro

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

  2. Tanaka, Ryota

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

  3. Tiwari, Shuchita

    1. The Heme Oxygenase System Selectively Enhances the Anti-Inflammatory Macrophage-M2 Phenotype, Reduces Pericardial Adiposity, and Ameliorated Cardiac Injury in Diabetic Cardiomyopathy in Zucker Diabetic Fatty Rats
      Ashok Jadhav, Shuchita Tiwari, Paul Lee and Joseph Fomusi Ndisang
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 239-249; DOI: https://doi.org/10.1124/jpet.112.200808

  4. Trznadel, Megan

    1. Novel Insights into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified between the Extracellular-3 Loop and Transmembrane Helix 2
      Jahan Marcu, Derek M. Shore, Ankur Kapur, Megan Trznadel, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 189-197; DOI: https://doi.org/10.1124/jpet.112.201046

W

  1. Wang, Xueding

    1. The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure
      Michael H. Court, Marina Freytsis, Xueding Wang, Inga Peter, Chantal Guillemette, Suwagmani Hazarika, Su X. Duan, David J. Greenblatt, William M. Lee and the Acute Liver Failure Study Group
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 297-307; DOI: https://doi.org/10.1124/jpet.112.202010

  2. Ward, Robert M.

    1. Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
      Jessica K. Roberts, Chad D. Moore, Robert M. Ward, Garold S. Yost and Christopher A. Reilly
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 308-316; DOI: https://doi.org/10.1124/jpet.112.202556

  3. Watanabe, Hiroshi

    1. Long-Acting Human Serum Albumin-Thioredoxin Fusion Protein Suppresses Bleomycin-Induced Pulmonary Fibrosis Progression
      Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Keisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri and Toru Maruyama
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 271-283; DOI: https://doi.org/10.1124/jpet.112.201814

  4. Webb, Edward F.

    1. Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases
      Michael Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, Christopher J. DeHaas, Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W. P. Hay and William L. Rumsey
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 260-270; DOI: https://doi.org/10.1124/jpet.112.202051

  5. Wei, Yu-Miao

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  6. Werner, David F.

    1. Ethanol Activation of Protein Kinase A Regulates GABAA α1 Receptor Function and Trafficking in Cultured Cerebral Cortical Neurons
      Stephen L. Carlson, Sandeep Kumar, David F. Werner, Christopher E. Comerford and A. Leslie Morrow
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 317-325; DOI: https://doi.org/10.1124/jpet.112.201954

  7. Wong, Min

    1. Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
      Fen-Fen Lin, Robin Elliott, Anne Colombero, Kevin Gaida, Laura Kelley, Angelica Moksa, Shu-Yin Ho, Ekaterina Bykova, Min Wong, Palaniswami Rathanaswami, Sylvia Hu, John K. Sullivan, Hung Q. Nguyen and Helen J. McBride
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 225-238; DOI: https://doi.org/10.1124/jpet.112.202788

X

  1. Xia, Min

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  2. Xiong, Jing

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

Y

  1. Yost, Garold S.

    1. Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes
      Jessica K. Roberts, Chad D. Moore, Robert M. Ward, Garold S. Yost and Christopher A. Reilly
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 308-316; DOI: https://doi.org/10.1124/jpet.112.202556

Z

  1. Zagorski, John

    1. A Novel Nontoxic Inhibitor of the Activation of NADPH Oxidase Reduces Reactive Oxygen Species Production in Mouse Lung
      Intae Lee, Chandra Dodia, Shampa Chatterjee, John Zagorski, Clementina Mesaros, Ian A. Blair, Sheldon I. Feinstein, Mahendra Jain and Aron B. Fisher
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 284-296; DOI: https://doi.org/10.1124/jpet.112.201079

  2. Zambrowicz, Brian

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

  3. Zhang, Yang

    1. Attenuation by Statins of Membrane Raft-Redox Signaling in Coronary Arterial Endothelium
      Yu-Miao Wei, Xiang Li, Jing Xiong, Justine M. Abais, Min Xia, Krishna M. Boini, Yang Zhang and Pin-Lan Li
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 170-179; DOI: https://doi.org/10.1124/jpet.112.201442

  4. Zhao, Sharon

    1. LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
      David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding
      Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364
Back to top

In this issue

Advertisement